Showing results (41-50 of 81) with videos related to

Sort By:
Pageof 9
American Journal of Clinical Oncology|June 1, 2004
Gemcitabine in patients with solid tumors and renal impairment: a pharmacokinetic phase I studySuzette Delaloge, Antonio Llombart, Mario Di Palma, et al.
Chinese Clinical Oncology|January 6, 2016
Subclavian artery resection and reconstruction for thoracic inlet neoplasmsOlaf Mercier, Xiao-Dong Su, Benoit Lahon, et al.
Pathology, Research and Practice|May 31, 2017
EGFR and KRAS molecular genotyping for pulmonary carcinomas: Feasibility of a simple and rapid technique implementable in any department of pathologyVincent Thomas De Montpréville, Maria-Rosa Ghigna, Ludovic Lacroix, et al.
Lung Cancer (Amsterdam, Netherlands)|July 18, 2003
Ongoing and future trials of biologic therapies in lung cancerPaul A Bunn, Frances A Shepherd, Alan Sandler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2004
Nuclear localization of apoptosis protease activating factor-1 predicts survival after tumor resection in early-stage non-small cell lung cancerBenjamin Besse, Céline Candé, Jean-Philippe Spano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2006
Erlotinib for frontline treatment of advanced non-small cell lung cancer: a phase II studyGiuseppe Giaccone, Marielle Gallegos Ruiz, Thierry Le Chevalier, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 6, 2002
Radical en bloc resection for lung cancer invading the spineDominique H Grunenwald, Christian Mazel, Philippe Girard, et al.
Lung Cancer (Amsterdam, Netherlands)|February 17, 2005
Epidermal growth factor receptor, HER-2/neu and related pathways in lung adenocarcinomas with bronchioloalveolar featuresMustafa Erman, Dominique Grunenwald, Frederique Penault-Llorca, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2004
Phase II study of pemetrexed-gemcitabine combination in patients with advanced-stage non-small cell lung cancerChristian Monnerat, Thierry Le Chevalier, Karen Kelly, et al.
The Lancet. Oncology|July 5, 2005
Cutaneous side-effects of kinase inhibitors and blocking antibodiesCaroline Robert, Jean-Charles Soria, Alain Spatz, et al.
Pageof 9